1. Home
  2. AGM vs MIRM Comparison

AGM vs MIRM Comparison

Compare AGM & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AGM
  • MIRM
  • Stock Information
  • Founded
  • AGM 1987
  • MIRM 2018
  • Country
  • AGM United States
  • MIRM United States
  • Employees
  • AGM N/A
  • MIRM N/A
  • Industry
  • AGM Finance Companies
  • MIRM Biotechnology: Pharmaceutical Preparations
  • Sector
  • AGM Finance
  • MIRM Health Care
  • Exchange
  • AGM Nasdaq
  • MIRM Nasdaq
  • Market Cap
  • AGM 2.2B
  • MIRM 2.0B
  • IPO Year
  • AGM N/A
  • MIRM 2019
  • Fundamental
  • Price
  • AGM $192.33
  • MIRM $42.04
  • Analyst Decision
  • AGM Hold
  • MIRM Strong Buy
  • Analyst Count
  • AGM 1
  • MIRM 11
  • Target Price
  • AGM $205.00
  • MIRM $57.00
  • AVG Volume (30 Days)
  • AGM 38.0K
  • MIRM 376.0K
  • Earning Date
  • AGM 02-21-2025
  • MIRM 02-26-2025
  • Dividend Yield
  • AGM 2.88%
  • MIRM N/A
  • EPS Growth
  • AGM 0.71
  • MIRM N/A
  • EPS
  • AGM 15.55
  • MIRM N/A
  • Revenue
  • AGM $347,661,000.00
  • MIRM $307,028,000.00
  • Revenue This Year
  • AGM N/A
  • MIRM $82.14
  • Revenue Next Year
  • AGM $6.65
  • MIRM $26.18
  • P/E Ratio
  • AGM $12.49
  • MIRM N/A
  • Revenue Growth
  • AGM 2.91
  • MIRM 112.14
  • 52 Week Low
  • AGM $169.17
  • MIRM $23.14
  • 52 Week High
  • AGM $217.60
  • MIRM $48.89
  • Technical
  • Relative Strength Index (RSI)
  • AGM 31.95
  • MIRM 47.79
  • Support Level
  • AGM $193.82
  • MIRM $40.91
  • Resistance Level
  • AGM $198.80
  • MIRM $42.40
  • Average True Range (ATR)
  • AGM 4.81
  • MIRM 1.45
  • MACD
  • AGM -1.72
  • MIRM -0.13
  • Stochastic Oscillator
  • AGM 12.94
  • MIRM 51.04

About AGM Federal Agricultural Mortgage Corporation

Federal Agricultural Mortgage Corp provides agricultural real estate and rural housing mortgage loans in the secondary market in the U.S. Its operations consist of seven segments: Farm & Ranch, Corporate AgFinance, Rural Utilities, Renewable Energy, Funding, Investments, and Corporate. The company purchases eligible mortgage loans secured by first liens on agricultural real estate and rural housing under the Farm & Ranch line of business. Its subsidiary purchases portions of certain agricultural, rural development, business and industry, and community facilities loans guaranteed by the USDA.

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter "IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

Share on Social Networks: